How to Follow, Manage and Treat Cardiac Dysfunction in Patients With Her2+ Breast Cancer

Anne Blaes, Charlotte Manisty, Ana Barac

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)661-665
Number of pages5
JournalJACC: CardioOncology
Volume2
Issue number4
DOIs
StatePublished - Nov 2020

Keywords

  • breast cancer
  • cardiotoxicity
  • heart failure
  • HER2 targeted therapy
  • LV dysfunction
  • trastuzumab

Cite this